UroGen Pharma Vs. Nukkleus Industry Stock Comparison

Sell

22

URGN
UroGen Pharma

Last Price:

$10.66

Seasonality Move:

-3.79%

Sell

46

NUKK
Nukkleus

Last Price:

$40.15

Seasonality Move:

-21.57%

Sell

22

UroGen Pharma (URGN) is a Sell

Is UroGen Pharma a Buy, Sell or Hold?

The current UroGen Pharma [URGN] share price is $10.67. The Score for URGN is 22, which is 56% below its historic median score of 50, and infers higher risk than normal.
URGN is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

Sell

46

Nukkleus (NUKK) is a Sell

Is Nukkleus a Buy, Sell or Hold?

The current Nukkleus [NUKK] share price is $40.00. The Score for NUKK is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
NUKK is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

URGN Stock Price Chart

What is UroGen Pharma's stock price today?

The UroGen Pharma share price today is $10.67

Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and URGN is experiencing slight selling pressure.

NUKK Stock Price Chart

What is Nukkleus's stock price today?

The Nukkleus share price today is $40.00

Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and NUKK is experiencing slight selling pressure.

URGN Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	-0.36	Sell
Relative Strength Index (14 RSI):	30.29	Sell
Chaikin Money Flow:	-612616	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(11.1 - 12.42)	Sell
Bollinger Bands (100):	(11.7 - 14.2)	Sell

NUKK Technical Analysis

Chart Indicators	Level	Buy or Sell
MACD (12, 26):	8.69	Buy
Relative Strength Index (14 RSI):	77.28	Buy
Chaikin Money Flow:	-1366926	-

Bollinger Bands	Level	Buy or Sell
Bollinger Bands (25):	(-7.5 - 22.6)	Buy
Bollinger Bands (100):	(-4.22 - 11.5)	Buy

URGN Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	11.14	Sell
20-day SMA:	11.89	Sell
50-day SMA:	12.03	Sell
200-day SMA:	13.95	Sell
8-day EMA:	11.14	Sell
20-day EMA:	11.58	Sell
50-day EMA:	12.09	Sell
200-day EMA:	13.45	Sell

NUKK Moving Averages

Moving Averages	Level	Buy or Sell
8-day SMA:	20.07	Buy
20-day SMA:	9	Buy
50-day SMA:	4.99	Buy
200-day SMA:	4.78	Buy
8-day EMA:	26.51	Buy
20-day EMA:	14.21	Buy
50-day EMA:	7.47	Buy
200-day EMA:	11.77	Buy

UroGen Pharma Earnings Growth & URGN Earnings Dates

Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.48 per share, and an increase next year of $0.42 per share.

Nukkleus Earnings Growth & NUKK Earnings Dates

Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

UroGen Pharma Technical Analysis

	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20
	Dec
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Nukkleus Technical Analysis

	Dec 9	Dec 10	Dec 11	Dec 12	Dec 13	Dec 16	Dec 17	Dec 18	Dec 19	Dec 20
	Dec
	09	10	11	12	13	16	17	18	19	20
Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):